Global Opioids Drugs Market Insights and Forecast to 2026

Global Opioids Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Opioids Drugs Product Introduction
1.2 Market Segments
1.3 Key Opioids Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Opioids Drugs Market Size Growth Rate by Type
1.4.2 Oxycodone
1.4.3 Hydromorphone
1.4.4 Codeine
1.4.5 Fentanyl
1.4.6 Other
1.5 Market by Application
1.5.1 Global Opioids Drugs Market Size Growth Rate by Application
1.5.2 Pain Relief
1.5.3 Anesthesia
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Opioids Drugs Market Size, Estimates and Forecasts
2.1.1 Global Opioids Drugs Revenue 2015-2026
2.1.2 Global Opioids Drugs Sales 2015-2026
2.2 Global Opioids Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Opioids Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Opioids Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Opioids Drugs Competitor Landscape by Players
3.1 Opioids Drugs Sales by Manufacturers
3.1.1 Opioids Drugs Sales by Manufacturers (2015-2020)
3.1.2 Opioids Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Opioids Drugs Revenue by Manufacturers
3.2.1 Opioids Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Opioids Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Opioids Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Opioids Drugs Revenue in 2019
3.2.5 Global Opioids Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Opioids Drugs Price by Manufacturers
3.4 Opioids Drugs Manufacturing Base Distribution, Product Types
3.4.1 Opioids Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioids Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Opioids Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Opioids Drugs Market Size by Type (2015-2020)
4.1.1 Global Opioids Drugs Sales by Type (2015-2020)
4.1.2 Global Opioids Drugs Revenue by Type (2015-2020)
4.1.3 Opioids Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Opioids Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Opioids Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Opioids Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Opioids Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Opioids Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Opioids Drugs Market Size by Application (2015-2020)
5.1.1 Global Opioids Drugs Sales by Application (2015-2020)
5.1.2 Global Opioids Drugs Revenue by Application (2015-2020)
5.1.3 Opioids Drugs Price by Application (2015-2020)
5.2 Opioids Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Opioids Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Opioids Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Opioids Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Opioids Drugs by Country
6.1.1 North America Opioids Drugs Sales by Country
6.1.2 North America Opioids Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Opioids Drugs Market Facts & Figures by Type
6.3 North America Opioids Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Opioids Drugs by Country
7.1.1 Europe Opioids Drugs Sales by Country
7.1.2 Europe Opioids Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioids Drugs Market Facts & Figures by Type
7.3 Europe Opioids Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Opioids Drugs by Region
8.1.1 Asia Pacific Opioids Drugs Sales by Region
8.1.2 Asia Pacific Opioids Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Opioids Drugs Market Facts & Figures by Type
8.3 Asia Pacific Opioids Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Opioids Drugs by Country
9.1.1 Latin America Opioids Drugs Sales by Country
9.1.2 Latin America Opioids Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Opioids Drugs Market Facts & Figures by Type
9.3 Central & South America Opioids Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Opioids Drugs by Country
10.1.1 Middle East and Africa Opioids Drugs Sales by Country
10.1.2 Middle East and Africa Opioids Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Opioids Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Opioids Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Purdue Pharma
11.1.1 Purdue Pharma Corporation Information
11.1.2 Purdue Pharma Description and Business Overview
11.1.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Purdue Pharma Opioids Drugs Products Offered
11.1.5 Purdue Pharma Related Developments
11.2 J&J
11.2.1 J&J Corporation Information
11.2.2 J&J Description and Business Overview
11.2.3 J&J Sales, Revenue and Gross Margin (2015-2020)
11.2.4 J&J Opioids Drugs Products Offered
11.2.5 J&J Related Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Description and Business Overview
11.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Opioids Drugs Products Offered
11.3.5 Teva Related Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Description and Business Overview
11.4.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mylan Opioids Drugs Products Offered
11.4.5 Mylan Related Developments
11.5 Depomed
11.5.1 Depomed Corporation Information
11.5.2 Depomed Description and Business Overview
11.5.3 Depomed Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Depomed Opioids Drugs Products Offered
11.5.5 Depomed Related Developments
11.6 INSYS
11.6.1 INSYS Corporation Information
11.6.2 INSYS Description and Business Overview
11.6.3 INSYS Sales, Revenue and Gross Margin (2015-2020)
11.6.4 INSYS Opioids Drugs Products Offered
11.6.5 INSYS Related Developments
11.7 Endo
11.7.1 Endo Corporation Information
11.7.2 Endo Description and Business Overview
11.7.3 Endo Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Endo Opioids Drugs Products Offered
11.7.5 Endo Related Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description and Business Overview
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Opioids Drugs Products Offered
11.8.5 Pfizer Related Developments
11.9 Hikma
11.9.1 Hikma Corporation Information
11.9.2 Hikma Description and Business Overview
11.9.3 Hikma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hikma Opioids Drugs Products Offered
11.9.5 Hikma Related Developments
11.10 Mallinckrodt
11.10.1 Mallinckrodt Corporation Information
11.10.2 Mallinckrodt Description and Business Overview
11.10.3 Mallinckrodt Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Mallinckrodt Opioids Drugs Products Offered
11.10.5 Mallinckrodt Related Developments
11.1 Purdue Pharma
11.1.1 Purdue Pharma Corporation Information
11.1.2 Purdue Pharma Description and Business Overview
11.1.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Purdue Pharma Opioids Drugs Products Offered
11.1.5 Purdue Pharma Related Developments
11.12 Egalet
11.12.1 Egalet Corporation Information
11.12.2 Egalet Description and Business Overview
11.12.3 Egalet Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Egalet Products Offered
11.12.5 Egalet Related Developments
11.13 Vistapharm
11.13.1 Vistapharm Corporation Information
11.13.2 Vistapharm Description and Business Overview
11.13.3 Vistapharm Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Vistapharm Products Offered
11.13.5 Vistapharm Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Opioids Drugs Market Estimates and Projections by Region
12.1.1 Global Opioids Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Opioids Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Opioids Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Opioids Drugs Sales Forecast (2021-2026)
12.2.2 North America: Opioids Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Opioids Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Opioids Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Opioids Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Opioids Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Opioids Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Opioids Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Opioids Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Opioids Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Opioids Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Opioids Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Opioids Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Opioids Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Opioids Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Opioids Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Opioids Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Opioids Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Opioids Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Opioids Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Opioids Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Opioids Drugs Market Segments
Table 2. Ranking of Global Top Opioids Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Opioids Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oxycodone
Table 5. Major Manufacturers of Hydromorphone
Table 6. Major Manufacturers of Codeine
Table 7. Major Manufacturers of Fentanyl
Table 8. Major Manufacturers of Other
Table 9. Global Opioids Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Opioids Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Opioids Drugs Sales by Regions 2015-2020 (K Units)
Table 12. Global Opioids Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Opioids Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Opioids Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Opioids Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Opioids Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Opioids Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Drugs as of 2019)
Table 18. Opioids Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Opioids Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Opioids Drugs Price (2015-2020) (USD/Unit)
Table 21. Opioids Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Opioids Drugs Product Type
Table 23. Date of International Manufacturers Enter into Opioids Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Opioids Drugs Sales by Type (2015-2020) (K Units)
Table 26. Global Opioids Drugs Sales Share by Type (2015-2020)
Table 27. Global Opioids Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Opioids Drugs Revenue Share by Type (2015-2020)
Table 29. Opioids Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Opioids Drugs Sales by Application (2015-2020) (K Units)
Table 31. Global Opioids Drugs Sales Share by Application (2015-2020)
Table 32. North America Opioids Drugs Sales by Country (2015-2020) (K Units)
Table 33. North America Opioids Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Opioids Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Opioids Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Opioids Drugs Sales by Type (2015-2020) (K Units)
Table 37. North America Opioids Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Opioids Drugs Sales by Application (2015-2020) (K Units)
Table 39. North America Opioids Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Opioids Drugs Sales by Country (2015-2020) (K Units)
Table 41. Europe Opioids Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Opioids Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Opioids Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Opioids Drugs Sales by Type (2015-2020) (K Units)
Table 45. Europe Opioids Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Opioids Drugs Sales by Application (2015-2020) (K Units)
Table 47. Europe Opioids Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Opioids Drugs Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Opioids Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Opioids Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Opioids Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Opioids Drugs Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Opioids Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Opioids Drugs Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Opioids Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Opioids Drugs Sales by Country (2015-2020) (K Units)
Table 57. Latin America Opioids Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Opioids Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Opioids Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Opioids Drugs Sales by Type (2015-2020) (K Units)
Table 61. Latin America Opioids Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Opioids Drugs Sales by Application (2015-2020) (K Units)
Table 63. Latin America Opioids Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Opioids Drugs Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Opioids Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Opioids Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Opioids Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Opioids Drugs Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Opioids Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Opioids Drugs Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Opioids Drugs Sales Market Share by Application (2015-2020)
Table 72. Purdue Pharma Corporation Information
Table 73. Purdue Pharma Description and Major Businesses
Table 74. Purdue Pharma Opioids Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Purdue Pharma Product
Table 76. Purdue Pharma Recent Development
Table 77. J&J Corporation Information
Table 78. J&J Description and Major Businesses
Table 79. J&J Opioids Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. J&J Product
Table 81. J&J Recent Development
Table 82. Teva Corporation Information
Table 83. Teva Description and Major Businesses
Table 84. Teva Opioids Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Teva Product
Table 86. Teva Recent Development
Table 87. Mylan Corporation Information
Table 88. Mylan Description and Major Businesses
Table 89. Mylan Opioids Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Mylan Product
Table 91. Mylan Recent Development
Table 92. Depomed Corporation Information
Table 93. Depomed Description and Major Businesses
Table 94. Depomed Opioids Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Depomed Product
Table 96. Depomed Recent Development
Table 97. INSYS Corporation Information
Table 98. INSYS Description and Major Businesses
Table 99. INSYS Opioids Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. INSYS Product
Table 101. INSYS Recent Development
Table 102. Endo Corporation Information
Table 103. Endo Description and Major Businesses
Table 104. Endo Opioids Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Endo Product
Table 106. Endo Recent Development
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Opioids Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Pfizer Product
Table 111. Pfizer Recent Development
Table 112. Hikma Corporation Information
Table 113. Hikma Description and Major Businesses
Table 114. Hikma Opioids Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Hikma Product
Table 116. Hikma Recent Development
Table 117. Mallinckrodt Corporation Information
Table 118. Mallinckrodt Description and Major Businesses
Table 119. Mallinckrodt Opioids Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Mallinckrodt Product
Table 121. Mallinckrodt Recent Development
Table 122. Pernix Corporation Information
Table 123. Pernix Description and Major Businesses
Table 124. Pernix Opioids Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. Pernix Product
Table 126. Pernix Recent Development
Table 127. Egalet Corporation Information
Table 128. Egalet Description and Major Businesses
Table 129. Egalet Opioids Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. Egalet Product
Table 131. Egalet Recent Development
Table 132. Vistapharm Corporation Information
Table 133. Vistapharm Description and Major Businesses
Table 134. Vistapharm Opioids Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 135. Vistapharm Product
Table 136. Vistapharm Recent Development
Table 137. Global Opioids Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 138. Global Opioids Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 139. Global Opioids Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 140. Global Opioids Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 141. North America: Opioids Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 142. North America: Opioids Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Europe: Opioids Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 144. Europe: Opioids Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Asia Pacific: Opioids Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 146. Asia Pacific: Opioids Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 147. Latin America: Opioids Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 148. Latin America: Opioids Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Middle East and Africa: Opioids Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 150. Middle East and Africa: Opioids Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 152. Key Challenges
Table 153. Market Risks
Table 154. Main Points Interviewed from Key Opioids Drugs Players
Table 155. Opioids Drugs Customers List
Table 156. Opioids Drugs Distributors List
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Drugs Product Picture
Figure 2. Global Opioids Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oxycodone Product Picture
Figure 4. Hydromorphone Product Picture
Figure 5. Codeine Product Picture
Figure 6. Fentanyl Product Picture
Figure 7. Other Product Picture
Figure 8. Global Opioids Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Pain Relief
Figure 10. Anesthesia
Figure 11. Other
Figure 12. Opioids Drugs Report Years Considered
Figure 13. Global Opioids Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Opioids Drugs Sales 2015-2026 (K Units)
Figure 15. Global Opioids Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Opioids Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Opioids Drugs Sales Market Share by Region in 2019
Figure 18. Global Opioids Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Opioids Drugs Revenue Market Share by Region in 2019
Figure 20. Global Opioids Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Opioids Drugs Revenue in 2019
Figure 22. Opioids Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Opioids Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Opioids Drugs Sales Market Share by Type in 2019
Figure 25. Global Opioids Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Opioids Drugs Revenue Market Share by Type in 2019
Figure 27. Global Opioids Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Opioids Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Opioids Drugs Sales Market Share by Application in 2019
Figure 30. Global Opioids Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Opioids Drugs Revenue Market Share by Application in 2019
Figure 32. North America Opioids Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Opioids Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Opioids Drugs Sales Market Share by Country in 2019
Figure 35. North America Opioids Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Opioids Drugs Market Share by Type in 2019
Figure 41. North America Opioids Drugs Market Share by Application in 2019
Figure 42. Europe Opioids Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Opioids Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Opioids Drugs Sales Market Share by Country in 2019
Figure 45. Europe Opioids Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Opioids Drugs Market Share by Type in 2019
Figure 57. Europe Opioids Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Opioids Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Opioids Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Opioids Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Opioids Drugs Revenue Market Share by Region in 2019
Figure 62. China Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Opioids Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Opioids Drugs Market Share by Application in 2019
Figure 86. Latin America Opioids Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Opioids Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Opioids Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Opioids Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Opioids Drugs Market Share by Type in 2019
Figure 97. Latin America Opioids Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Opioids Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Opioids Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Opioids Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Opioids Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Opioids Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Opioids Drugs Market Share by Application in 2019
Figure 110. North America Opioids Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Opioids Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Opioids Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Opioids Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Opioids Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Opioids Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Opioids Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Opioids Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Opioids Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Opioids Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs